Abstract
Single cell RNA sequencing has opened a window into clarifying the complex underpinnings of disease, particularly in quantifying the relevance of tissue- and cell-type-specific gene expression. To identify the cell types and genes important to therapeutic target development across the neurodegenerative disease spectrum, we leveraged genome-wide association studies, recent single cell sequencing data, and bulk expression studies in a diverse series of brain region tissues. We were able to identify significant immune-related cell types in the brain across three major neurodegenerative diseases: Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Parkinson’s Diseases. Subsequently, we identified the major role of 30 fine-mapped loci implicating seven genes in multiple neurodegenerative diseases and their pathogenesis.
Competing Interest Statement
CXA, CAW, NJ, HLL and MAN declare that they are consultants employed by Data Tecnica International, whose participation in this is part of a consulting agreement between the US National Institutes of Health and said company. MAN also an advisor to Neuron23 Inc and Character Biosciences.
Funding Statement
We would like to thank all of the subjects who donated their time and biological samples to the studies that are reflected in these analyses. This research was supported in part by the Intramural Research Program of the National Institutes of Health (National Institute on Aging and National Institute of Neurological Disorders and Stroke; project numbers: 1ZIAAG00935, 1ZIANS003154, Z01-AG000949-02). This study used the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health (http://hpc.nih.gov).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data. All GWAS summary statistics used in this report are available at https://nih-card-ndd-smr-home-syboky.streamlit.app/About. Single nucleus (sn) RNA-seq expression data is available at https://github.com/linnarsson-lab/adult-human-brain which is the repository associated with https://doi.org/10.1101/2022.10.12.511898. eQTL data is available at the MetaBrain browser: https://www.metabrain.nl/.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All GWAS summary statistics used in this report are available at https://nih-card-ndd-smr-home-syboky.streamlit.app/About Single nucleus (sn) RNA-seq expression data is available at https://github.com/linnarsson-lab/adult-human-brain which is the repository associated with https://doi.org/10.1101/2022.10.12.511898 eQTL data is available at the MetaBrain browser: https://www.metabrain.nl/ Code used for analysis is available at https://github.com/NIH-CARD/NDD_Single_Cell
https://github.com/NIH-CARD/NDD_Single_Cell
https://nih-card-ndd-smr-home-syboky.streamlit.app/About
